AdaptHealth Corp. (AHCO) financials: revenue, earnings and cash flow
Fiscal 2018–2025 + TTM · from SEC filings · data as of November 13, 2026
Summary
AdaptHealth’s revenue went from $345M in fiscal 2018 to $3.2B in fiscal 2025, growth of about 37.7% a year.
Net income in fiscal 2025 was -$71M, a net margin of -2.2%; the best year in this period was 2021 with $156M.
Over the twelve months to September 30, 2026, revenue was $3.4B and net income -$407M.
Free cash flow was $219M in fiscal 2025 and positive in 7 of the 8 years shown.
The diluted share count rose 1036% over the period (dilution).
Revenue, profit and cash flow by year
Income statement
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $3.4B | $3.2B | $3.3B | $3.2B | $3.0B | $2.5B | $1.1B | $530M | $345M |
| Gross profit | $560M | $609M | $681M | $624M | $580M | $446M | $158M | $89M | $52M |
| Operating income | -$320M | $91M | $264M | -$598M | $190M | $226M | $71M | $29M | $31M |
| Net income | -$407M | -$71M | $90M | -$679M | $69M | $156M | -$162M | -$21M | $23M |
| EPS (diluted) | $-2.98 | $-0.52 | $0.61 | $-5.31 | $0.33 | $0.67 | $-3.08 | $-0.95 | $1.95 |
| R&D | — | — | — | — | — | — | — | — | — |
| Revenue growth | — | −0.5% | +1.9% | +7.7% | +21.0% | +132.3% | +99.5% | +53.4% | — |
Cash flow
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $579M | $602M | $542M | $481M | $374M | $276M | $196M | $60M | $68M |
| Capital spending | -$497M | -$382M | -$306M | -$337M | -$391M | -$203M | -$40M | -$21M | -$10M |
| Free cash flow | $82M | $219M | $236M | $143M | -$18M | $72M | $156M | $39M | $58M |
| Dividends paid | — | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Buybacks | — | $0 | $0 | $29M | $14M | $0 | $0 | $20M | — |
| Stock-based pay | $18M | $22M | $15M | $22M | $22M | $25M | $19M | $11M | $883373 |
Balance sheet
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Cash | — | $106M | $110M | $77M | $46M | $150M | $100M | $77M | $947098 |
| Debt | — | $1.9B | $2.1B | $2.3B | $2.3B | $2.4B | $785M | $397M | $134M |
| Equity | — | $1.5B | $1.6B | $1.5B | $2.2B | $2.1B | $355M | -$39M | $5M |
| Total assets | — | $4.3B | $4.5B | $4.5B | $5.2B | $5.3B | $1.8B | $547M | $369M |
| Shares (diluted) | 136M | 135M | 136M | 134M | 139M | 133M | 52M | 23M | 12M |
Margins and returns
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 16.3% | 18.8% | 20.9% | 19.5% | 19.5% | 18.1% | 14.9% | 16.8% | 15.0% |
| Operating margin | -9.3% | 2.8% | 8.1% | -18.7% | 6.4% | 9.2% | 6.8% | 5.5% | 9.0% |
| Net margin | -11.8% | -2.2% | 2.8% | -21.2% | 2.3% | 6.4% | -15.3% | -4.0% | 6.7% |
| FCF margin | 2.4% | 6.8% | 7.2% | 4.5% | -0.6% | 2.9% | 14.8% | 7.4% | 16.9% |
| ROIC | — | 2.1% | 5.0% | -15.0% | 3.2% | 4.2% | 5.9% | 6.5% | 17.6% |
| ROE | — | -4.7% | 5.8% | -46.6% | 3.2% | 7.6% | -45.5% | 55.0% | 465.2% |
Frequently asked questions
What is AdaptHealth’s annual revenue?
$3.2B in fiscal 2025 and $3.4B over the twelve months to September 30, 2026.
How much profit does AdaptHealth make?
Net income was -$71M in fiscal 2025 (net margin -2.2%).
Is AdaptHealth’s revenue growing?
No: revenue fell 0.5% in fiscal 2025 compared with the year before.
From the company’s 10-K and 10-Q filings with the SEC; per-share figures adjusted for stock splits. Rebuilt daily. Not investment advice.